CLPT - Company ID 0001285550
The table below shows ClearPoint Neuro, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$23.90M | -$8.95M | -$13.72M | -$16.17M | -$12.70M | -$7.81M |
| Capital expenditure | $522.00K | $275.00K | $717.00K | $253.00K | $168.00K | $41.00K |
| Investing cash flow | $615.00K | -$275.00K | $8.95M | -$10.74M | -$168.00K | -$482.00K |
| Dividends paid | - | - | - | - |
ClearPoint Neuro, Inc. reported operating cash flow of -$23.90M for fiscal year 2025. That is down 167.0% from -$8.95M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.82M (FY 2016) to -$23.90M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $50.18M | $6.19M | $296.00K | $409.00K | $46.88M | $22.69M |